Brain Cancer
📧 Sign up to get email alerts when something new happens for Brain Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-12-15Clinical Trial Update: 1 Week Versus 6 Weeks of Levetiracetam in Surgical Brain Tumor Patients [Phase 4]
Phase 4 trial comparing 1 week versus 6 weeks of levetiracetam in patients with surgical brain tumors; results completed with results posted…
-
CLINICAL_TRIALS trial_result · 2021-09-16Clinical Trial Update: Tarceva With Whole Brain Radiation Therapy - Brain Mets From Non-Small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial evaluating the combination of Tarceva (erlotinib) with whole brain radiation therapy for brain metastases from non-sm…
-
CLINICAL_TRIALS trial_result · 2021-08-25Clinical Trial Update: Phase I / II Vorinostat, Erlotinib and Temozolomide for Recurrent Glioblastoma Multiforme (GBM) [Phase 1, Phase 2]
Phase I/II trial of vorinostat, erlotinib, and temozolomide in recurrent glioblastoma multiforme (GBM) was terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2021-08-10Clinical Trial Update: A Phase II Study of Optune (NovoTTF) in Combination With Bevacizumab (BEV) and Temozolomide (TMZ) in Patients With Newly Diagnosed Unresectable Glioblastoma (GBM) [Phase 2]
Phase II study evaluating Optune (NovoTTF) with Bevacizumab and Temozolomide in newly diagnosed unresectable glioblastoma; trial terminated …
-
CLINICAL_TRIALS trial_result · 2021-07-15Clinical Trial Update: Combination Adenovirus + Pembrolizumab to Trigger Immune Virus Effects [Phase 2]
Phase 2 trial evaluating combination of an oncolytic adenovirus with pembrolizumab for brain cancers has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-03-30Clinical Trial Update: External Beam Radiation Therapy and Cetuximab Followed by Irinotecan and Cetuximab for Children and Young Adults With Newly Diagnosed Diffuse Pontine Tumors and High-Grade Astrocytomas [Phase 2]
A Phase 2 clinical trial evaluating external beam radiation therapy with cetuximab, followed by irinotecan and cetuximab, in children and yo…
-
CLINICAL_TRIALS trial_result · 2021-03-15Clinical Trial Update: IDH1 Peptide Vaccine for Recurrent Grade II Glioma [Phase 1]
Phase 1 trial update of an IDH1 peptide vaccine for recurrent grade II glioma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-12-17Clinical Trial Update: Imaging Brain Tumors With FACBC and Methionine [NA]
A completed clinical trial evaluating imaging methods using FACBC and methionine for brain tumors.
-
CLINICAL_TRIALS trial_result · 2020-12-17Clinical Trial Update: Image-Guided Stereotactic Biopsy of High Grade Gliomas [NA]
Clinical trial update on image-guided stereotactic biopsy for high-grade gliomas; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-10-19Clinical Trial Update: Clinical and Molecular-Metabolic Phase II Trial of Perifosine for Recurrent/Progressive Malignant Gliomas [Phase 2]
Phase II trial of perifosine for recurrent/progressive malignant gliomas completed; results posted.
-
CLINICAL_TRIALS trial_result · 2020-08-26Clinical Trial Update: Bevacizumab and Lapatinib in Children With Recurrent or Refractory Ependymoma [Phase 2]
A Phase 2 trial evaluating bevacizumab and lapatinib in children with recurrent or refractory ependymoma has been completed with results pos…
-
CLINICAL_TRIALS trial_result · 2020-04-06Clinical Trial Update: SarCNU in Treating Patients With Recurrent Malignant Glioma [Phase 2]
Phase 2 clinical trial update for SarCNU in patients with recurrent malignant glioma.
-
CLINICAL_TRIALS trial_result · 2020-03-17Clinical Trial Update: Standard Dose Bevacizumab Versus Low Dose Bevacizumab Plus Lomustine (CCNU) for Recurrent Glioblastoma Multiforme (GBM) [Phase 2]
Phase 2 trial comparing standard-dose bevacizumab to low-dose bevacizumab plus lomustine in recurrent glioblastoma multiforme (GBM); study c…
-
CLINICAL_TRIALS trial_result · 2020-03-16Clinical Trial Update: Exploratory Study, Evaluating the Treatment Effect of Surgery Plus GLIADEL® Wafer in Patients With Metastatic Brain Cancer [Phase 2]
Phase 2 exploratory study evaluating surgery plus GLIADEL wafers for metastatic brain cancer has completed with results posted.
-
CLINICAL_TRIALS research · 2020-01-22Clinical Trial Update: Study of Fractionated Stereotactic Radiosurgery to Treat Large Brain Metastases [NA]
Clinical trial completed evaluating fractionated stereotactic radiosurgery for large brain metastases; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2019-08-20Clinical Trial Update: Intercontinental Multidisciplinary Registry and Treatment Optimization Study for Choroid Plexus Tumors [Phase 3]
Phase 3 trial updating the Intercontinental Multidisciplinary Registry and Treatment Optimization Study for choroid plexus tumors was termin…
-
CLINICAL_TRIALS other · 2019-02-11Clinical Trial Update: Consent for Obtaining Additional Bone Marrow Specimens at Time of Diagnostic Bone Marrow Procedure
This clinical trial update addresses consent for obtaining additional bone marrow specimens at the time of diagnostic bone marrow procedures…
-
CLINICAL_TRIALS trial_result · 2018-07-16Clinical Trial Update: DNX-2401 (Formerly Known as Delta-24-RGD-4C) for Recurrent Malignant Gliomas [Phase 1]
Phase 1 clinical trial update reporting completion of DNX-2401 (Delta-24-RGD-4C) for recurrent malignant gliomas.
-
CLINICAL_TRIALS trial_result · 2018-05-29Clinical Trial Update: Feasibility Study of Tumor Blood Flow Measurement by Detection of Positron Activation Post Proton Therapy (DS01)
Terminated feasibility trial evaluating measurement of tumor blood flow via positron activation after proton therapy in brain, prostate, and…
-
CLINICAL_TRIALS trial_result · 2018-04-27Clinical Trial Update: [18F] FACBC and [18F] FLT PET Imaging in Central Nervous System Tumors [NA]
Clinical trial update reporting completed results for PET imaging using [18F] FACBC and [18F] FLT in patients with brain cancer and gliomas.
-
CLINICAL_TRIALS trial_result · 2018-04-17Clinical Trial Update: Temozolomide in Treating Patients With Primary Brain Tumors or Metastatic Brain Tumors [Phase 1]
A Phase 1 trial evaluating temozolomide for patients with primary brain tumors or brain metastases has been completed.
-
CLINICAL_TRIALS trial_result · 2018-02-06Clinical Trial Update: Bevacizumab, Temozolomide and Hypofractionated Radiotherapy for Patients With Newly Diagnosed Malignant Glioma [Phase 2]
Phase 2 trial evaluating bevacizumab, temozolomide, and hypofractionated radiotherapy in newly diagnosed malignant glioma; study status comp…
-
CLINICAL_TRIALS trial_result · 2018-01-23Clinical Trial Update: Radiation Therapy With or Without Temozolomide in Treating Older Patients With Newly Diagnosed Glioblastoma Multiforme [Phase 3]
Phase 3 trial evaluating radiation therapy with or without temozolomide in older adults with newly diagnosed glioblastoma multiforme has com…
-
CLINICAL_TRIALS trial_result · 2017-12-05Clinical Trial Update: MT2004-30: Tomotherapy for Solid Tumors [Phase 1]
This clinical trial update reports termination of MT2004-30 Tomotherapy for Solid Tumors in Phase 1. The study lists brain cancer, kidney ca…
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors [Phase 1]
A Phase 1 trial evaluating amifostine to protect against side effects of peripheral stem cell transplantation in patients with solid tumors …